About 500 reports

  • Diagnosis of lymphoma
  • Tests for lymphoma

About Lymphoma Drugs Lymphoma is a type of cancer that affects the immune system of the body. Specifically, it affects the lymphocytes, a type of white blood cell. The lymphocytes are part of the immune system and help the body to fight infections. The cancerous lymphocytes grow uncontrollably and collect in different portions...

  • Lymphoma
  • United States
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

You can request one free hour of our analyst’s time when you purchase this market report.

  • Lymphoma
  • Therapy
  • World
  • Market Size

Hoffmann-La Roche • Merck Sharp & Dohme • Novartis • Spectrum Pharmaceuticals About Burkitt Lymphoma Burkitt Lymphoma is one of the rare types of B-cell non-Hodgkin’s lymphoma.

  • Lymphoma
  • Therapy
  • World
  • Market Size
  • VII. LYMPHOMA
  • Lymphoma Treatment Drugs Imports and Exports

China’s demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Lymphoma
  • China
  • Shandong Luoxin Pharmacy Stock Co., Ltd.
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

You can request one free hour of our analyst’s time when you purchase this market report.

  • Lymphoma
  • Therapy
  • World
  • Market Size
  • Lymphoma Treatment Drugs Industry Structure
  • LYMPHOMA TREATMENT DRUGS INDUSTRY ASSESSMENTS

This study focuses on China’s Lymphoma Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Pfizer Inc.
  • Shandong Luoxin Pharmacy Stock Co., Ltd.
  • Other Lymphoma Treatment Drugs
  • Lymphoma Treatment Drugs Imports

This study focuses on China’s Lymphoma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Lymphoma
  • China
  • Demand
  • Trade
  • Jiangsu HengRui Medicine Co., Ltd.

The 2019-2024 World Outlook for Lymphoma Therapeutics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cancer
  • Lymphoma
  • World
  • Demand

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024 ##.

  • Cancer
  • Lymphoma
  • Therapy
  • World
  • Market Size

Indolent Lymphoma - Epidemiology Forecast to 2027 ##.

  • Lymphoma
  • France
  • Germany
  • Italy
  • Spain

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 TABLE OF CONTENTS Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## METHODOLOGY

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Small lymphocytic lymphoma -Epidemiology Forecast to 2027 ##.

  • Lymphoma
  • France
  • Germany
  • Italy
  • Spain

B-Cell Lymphomas - Epidemiology Forecast to 2027 ##.

  • Lymphoma
  • France
  • Germany
  • Italy
  • Spain

The disease often initially responds to treatment, but disease relapse inevitably occurs within ##–## years.

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

This cancer is the most common type of non-Hodgkin’s lymphoma (NHL), accounting for about one-third of all newly diagnosed cases.

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

Drug A: Company ## ##. ##. ##.

  • Cancer
  • Lymphoma
  • United States
  • Market Shares

Drug A: Company ## ##. ##. ##.

  • Cancer
  • Lymphoma
  • United States
  • Market Shares

Drug A: Company ## ##. ##. ##.

  • Cancer
  • Lymphoma
  • United States
  • Market Shares
  • Ann Arbor staging used in lymphoma
  • Pipeline: Diffuse Large B-Cell Lymphoma

An increase in disease prevalence and the launch of new targeted therapies across a range of treatment settings will drive the growth of the diffuse large B-cell lymphoma (DLBCL) market during 2016–25 despite Rituxan’s patent expiry. This report addresses the following questions: - What will drive the growth of the DLBCL...

  • Lymphoma
  • European Union
  • Japan
  • United States
  • Roche Group
  • EPIDEMIOLOGY: FOLLICULAR LYMPHOMA
  • Epidemiology: Follicular Lymphoma

The follicular lymphoma (FL) market will continue to grow during 2016–25, despite the entry of biosimilars and generics, due to an increase in disease incidence and the launch of new pipeline therapies. This report addresses the following questions: - What will be driving the growth of the FL market during 2016–25? -...

  • Lymphoma
  • European Union
  • Japan
  • North America
  • United States
  • TREATMENT: MANTLE CELL LYMPHOMA
  • Treatment: Mantle Cell Lymphoma

An increase in incident cases, combined with the expanded use of costly treatments such as Imbruvica and Revlimid, will drive the growth of the mantle cell lymphoma (MCL) market during 2016–25. This report addresses the following questions: - What will be driving the growth of the MCL market during 2016–25? - Which markets...

  • Lymphoma
  • European Union
  • United States
  • Celgene Corporation
  • Roche Group
  • 2.3.3 LYMPHOMA
  • 2.4.3 LYMPHOMA

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Summary Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against cancer cells. This...

  • Lymphoma
  • World
  • AbbVie Inc.
  • Aduro BioTech, Inc.
  • Amgen Inc.
  • 9.27 Lymphoma, Hodgkin's - Market & Forecast
  • 10.28 Lymphoma, Non-hodgkin's - Patient Numbers & Forecast

Rising incidences of Pediatric cancer has provoked medical organizations towards development and implementation of sophisticated treatment procedures, which is “Proton Radiotherapy”. The efficiency of proton therapy continues to add trust of Pediatric cancer patients globally. The course of action is known for successfully destructing tumor...

  • Lymphoma
  • North America
  • United States
  • Forecast
  • Market Size

There are various types of B-cell NHL including Burkitt lymphoma, chronic lymphocytic leukemia (CLL), follicular lymphoma, and mantle cell lymphoma.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • 3.5.1 Follicular Lymphoma
  • 3.5.4 Mantle Cell Lymphoma

EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2024 Summary Non-Hodgkin’s Lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the body’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fight...

  • Lymphoma
  • Japan
  • United States
  • World
  • Forecast
  • LYMPHOMA MARKET BY DRUG TYPE ($ MILLIONS)
  • Chapter 9: Pipeline Disruptors: Lymphoma

This report covers market opportunities based on pipeline developments for six key therapeutic specialities: Alzheimer's Disease Asthma Breast Cancer Leukemia Lung Cancer Lymphoma These six areas are expected to show the strongest pipeline impact and candidates are likely to replace current therapies. The...

  • Lymphoma
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • 9.2.1. LEUKEMIA AND LYMPHOMA
  • 9.2.1.2. LYMPHOMA: INTRODUCTION AND EPIDEMIOLOGY

INTRODUCTION Amidst the current initiatives to develop more targeted anti-cancer therapies, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a potent and viable therapeutic intervention to eradicate tumor cells, with minimal side effects. It is based on the principle of harnessing the innate potential of...

  • Lymphoma
  • China
  • Celgene Corporation
  • Juno Therapeutics Inc.
  • Novartis AG
  • DLBCL Treatment Algorithm
  • ABBREVIATIONS (1/2)

Biosimilars in Oncology Summary Recent trends in drug development have seen the price of new medicines continually increase, and there is a need for cheaper medicines to achieve global sustainable healthcare.Biologic drugs are some of the most expensive medicines to develop, as they are large complex...

  • Lymphoma
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Global Non-Hodgkins Lymphoma Epidemiology and Patient Flow Analysis - 2017 ##.

  • Lymphoma
  • France
  • United States
  • World
  • Forecast

This influence varies from one industry to another, but also from one period of time to another.

  • Cancer
  • Lymphoma
  • Therapy
  • World
  • Demand